Literature DB >> 8050316

Lack of evidence for hepatitis B virus (HBV) infection in fulminant non-A, non-B hepatitis.

T Laskus1, J Rakela, R H Wiesner, J L Steers, D H Persing.   

Abstract

We studied eight patients who had orthotopic liver transplantation for fulminant hepatic failure in the course of acute non-A, non-B hepatitis. HBV DNA was searched for extensively in the liver tissue by PCR using several sets of primers in conventional and heminested reactions. All patients were negative for HBV DNA in liver tissue by all assays employed; furthermore, they were negative for HEV RNA, HCV RNA, and HBV DNA in serum. Although the causative role of HEV and HCV in fulminant non-A, non-B hepatitis cannot be excluded, our data do not support a causative association between this syndrome and HBV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050316     DOI: 10.1007/bf02087775

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.

Authors:  M Omata; T Ehata; O Yokosuka; K Hosoda; M Ohto
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  Hepatitis C virus in fulminant hepatic failure.

Authors:  M Yanagi; S Kaneko; M Unoura; S Murakami; K Kobayashi; J Sugihara; H Ohnishi; Y Muto
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

Review 3.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

4.  Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States.

Authors:  T Laskus; D H Persing; M J Nowicki; J W Mosley; J Rakela
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

5.  Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

Authors:  C Féray; M Gigou; D Samuel; G Reyes; J Bernuau; M Reynes; H Bismuth; C Bréchot
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

6.  Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses.

Authors:  T J Liang; L Jeffers; R K Reddy; M O Silva; H Cheinquer; A Findor; M De Medina; P O Yarbough; G R Reyes; E R Schiff
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

7.  Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children.

Authors:  R Goldsmith; P O Yarbough; G R Reyes; K E Fry; K A Gabor; M Kamel; S Zakaria; S Amer; Y Gaffar
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

8.  Hepatitis B virus and apparent fulminant non-A, non-B hepatitis.

Authors:  T L Wright; D Mamish; C Combs; M Kim; E Donegan; L Ferrell; J Lake; J Roberts; N L Ascher
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

9.  Characterization of a prototype strain of hepatitis E virus.

Authors:  S A Tsarev; S U Emerson; G R Reyes; T S Tsareva; L J Legters; I A Malik; M Iqbal; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

  9 in total
  1 in total

1.  Hepatitis G virus infection in fulminant hepatic failure.

Authors:  J C Sáiz; M Sans; A Mas; E Olmedo; X Forns; F X López-Labrador; J C Restrepo; J Costa; J M Salmerón; M Guilera; S Ampurdanés; J M Sánchez-Tapias; M T Jiménez de Anta; J Rodés
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.